DME
Clinical trials for DME explained in plain language.
Never miss a new study
Get alerted when new DME trials appear
Sign up with your email to follow new studies for DME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill aims to save sight in diabetic eye disease
Disease control Not yet recruitingThis study tests an oral medication, CU06-1004, for people with diabetic macular edema (DME), a condition that causes vision loss. About 156 participants will take either a low dose, high dose, or placebo pill daily for 24 weeks. The goal is to see if the drug improves vision and…
Matched conditions: DME
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for diabetic eye disease: experimental drug SNP318 enters Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called SNP318 in 60 people with diabetic macular edema, a condition that causes vision loss due to swelling in the retina. Participants will receive either the drug or a placebo, and researchers will monitor safety, eye thickness, and vision …
Matched conditions: DME
Phase: PHASE2 • Sponsor: SciNeuro • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
AI assistant could sharpen eye injection choices
Diagnosis Not yet recruitingThis trial tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet AMD, DME, and RVO. About 200 patients who have completed initial treatment will be randomly assigned to have their doctor use …
Matched conditions: DME
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC